Furthermore, since PTHrP is up-regulated by HER1 and contributes to tumor malignancy downstream to HER1, we investigated if the expression of PTHrP and PTH1R could be prognostic and/or predictive biomarkers of sensitivity/resistance to bio-radiotherapy with cetuximab. This evidence concerns the gene PTH1R and neoplasm.